Cargando…

Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to (18)F–FDG-PET/CT

BACKGROUND: Gastro-intestinal stromal tumors (GISTs) are very rare tumors of the gastro-intestinal tract, originating from the interstitial cells of Cajal or a common cell precursor which both express type III tyrosine kinase receptors. Regorafenib is an oral multi-kinase inhibitor used to treat gas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Weehaeghe, Donatienne, Gheysens, Olivier, Vandecaveye, Vincent, Schöffski, Patrick, Van Laere, Koen, Deroose, Christophe M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836457/ https://www.ncbi.nlm.nih.gov/pubmed/29506493 http://dx.doi.org/10.1186/s12885-018-4154-7

Ejemplares similares

Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre
por: Chamberlain, Florence, et al.
Publicado: (2020)

The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I
por: Schöffski, Patrick, et al.
Publicado: (2014)

Minimally invasive quantification of cerebral P2X7R occupancy using dynamic [(18)F]JNJ-64413739 PET and MRA-driven image derived input function
por: Mertens, Nathalie, et al.
Publicado: (2021)

Neuroinflammation as potential precursor of leukoencephalopathy in early-stage breast cancer patients: A cross-sectional PET-MRI study
por: Schroyen, Gwen, et al.
Publicado: (2022)

EANM procedure guidelines for brain PET imaging using [(18)F]FDG, version 3
por: Guedj, Eric, et al.
Publicado: (2021)

FDG-PET findings in three cases of Mills’ syndrome
por: Van Laere, Koen, et al.
Publicado: (2016)

Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes
por: Devrome, Martijn, et al.
Publicado: (2018)

Correction to: EANM procedure guidelines for brain PET imaging using [(18)F]FDG, version 3
por: Guedj, Eric, et al.
Publicado: (2022)

2-[(18)F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee
por: Verger, Antoine, et al.
Publicado: (2022)

Regorafenib: Adding to the Armamentarium for Refractory Colorectal Cancer and GIST
por: Roman, Danielle, et al.
Publicado: (2013)

The Effect of Aging on Brain Glucose Metabolic Connectivity Revealed by [(18)F]FDG PET-MR and Individual Brain Networks
por: Mertens, Nathalie, et al.
Publicado: (2022)

Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [(18)F]FDG PET/CT
por: Montes de Jesus, Filipe, et al.
Publicado: (2021)

Simultaneous (18)F-FDG PET/MR metabolic and structural changes in visual snow syndrome and diagnostic use
por: Van Laere, Koen, et al.
Publicado: (2022)

Long-term Ashtanga yoga practice decreases medial temporal and brainstem glucose metabolism in relation to years of experience
por: van Aalst, June, et al.
Publicado: (2020)

Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2017)

Prospective comparison of [(18)F]AlF-NOTA-octreotide PET/MRI to [(68)Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
por: Boeckxstaens, Lennert, et al.
Publicado: (2023)

Construction and Evaluation of Quantitative Small-Animal PET Probabilistic Atlases for [(18)F]FDG and [(18)F]FECT Functional Mapping of the Mouse Brain
por: Casteels, Cindy, et al.
Publicado: (2013)

Imaging in Post-COVID Lung Disease: Does (18)F-FDG PET/CT Have the Key?
por: Gheysens, Olivier, et al.
Publicado: (2022)

Prognostic superiority of International Prognostic Index over [(18)F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder
por: Montes de Jesus, F., et al.
Publicado: (2021)

Gastro-intestinal stromal tumor (GIST) complicating a colonic interposition: a novel case report
por: Badshah, Maaz B, et al.
Publicado: (2014)

(18)F-FDG-PET/CT as an imaging biomarker for regorafenib efficacy in metastatic colorectal cancer (JACCRO CC-12)
por: Nakamura, Masato, et al.
Publicado: (2021)

Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI
por: Sharkey, Amy R., et al.
Publicado: (2021)

Gastrointestinal Stromal Tumours (GIST) in Young Adult (18–40 Years) Patients: A Report from the Dutch GIST Registry
por: IJzerman, Nikki S., et al.
Publicado: (2020)

Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients
por: Schiavon, Gaia, et al.
Publicado: (2012)

Role of [(18)F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors
por: Magi, Ludovica, et al.
Publicado: (2022)

Correction: Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients
por: Schiavon, Gaia, et al.
Publicado: (2013)

Clinical validation of the novel HDAC6 radiotracer [(18)F]EKZ-001 in the human brain
por: Koole, Michel, et al.
Publicado: (2020)

Identifying a glucose metabolic brain pattern in an adeno-associated viral vector based rat model for Parkinson’s disease using (18)F-FDG PET imaging
por: Devrome, Martijn, et al.
Publicado: (2019)

Correlation of Perfusion MRI and (18)F-FDG PET Imaging Biomarkers for Monitoring Regorafenib Therapy in Experimental Colon Carcinomas with Immunohistochemical Validation
por: Eschbach, Ralf S., et al.
Publicado: (2015)

Malignant diagnosis and prognostic analysis of 89 GIST patients using preoperative FDG-PET
por: Narushima, Kazuo, et al.
Publicado: (2023)

Intra-individual qualitative and quantitative comparison of [(68)Ga]Ga-DOTATATE PET/CT and PET/MRI
por: Lens, Géraldine, et al.
Publicado: (2023)

Ferroptosis Induction and YAP Inhibition as New Therapeutic Targets in Gastrointestinal Stromal Tumors (GISTs)
por: Delvaux, Marine, et al.
Publicado: (2022)

Semi-Quantitative and Quantitative [(18)F]FDG-PET/CT Indices for Diagnosing Large Vessel Vasculitis: A Critical Review
por: Gheysens, Olivier, et al.
Publicado: (2021)

[(18)F]FDG-PET/CT in Idiopathic Inflammatory Myopathies: Retrospective Data from a Belgian Cohort
por: Yildiz, Halil, et al.
Publicado: (2023)

Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial
por: Jeffers, Michael, et al.
Publicado: (2022)

Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China
por: Shi, Yi-Nan, et al.
Publicado: (2017)

The Role of Quantitative and Semi-quantitative [(18)F]FDG-PET/CT Indices for Evaluating Disease Activity and Management of Patients With Dermatomyositis and Polymyositis
por: Yildiz, Halil, et al.
Publicado: (2022)

(18)FDG-PET at 1-Month Intervals Is a Better Predictive Marker for GISTs That Are Difficult to Be Diagnosed Histopathologically: A Case Report
por: Otsuka, Kazunori, et al.
Publicado: (2011)

Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis
por: van der Geest, K. S. M., et al.
Publicado: (2020)

Cerebral glucose changes after chemotherapy and their relation to long-term cognitive complaints and fatigue
por: Schroyen, Gwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a4idpd5fvnjfdlffdbrb324leu